The blood analyzer and reagent market was valued at USD 3,654.18 million in 2018 and is expected to reach USD 6,344,230 by 2025, with a compound annual growth rate of 8.20% during the forecast period.
Hematology is a branch of medicine that involves the study, diagnosis, treatment and anticipation of blood-related diseases. Hematology analyzers and reagents can be used to diagnose various diseases related to red blood cells, white blood cells, platelets, and bone marrow, and proteins are involved in bleeding and coagulation. It can also regulate the plasma drug levels of therapeutic drugs and illegal drugs.
The global hematology analyzer and reagent market report is divided by product, application, end user, and regional and national levels. Based on the product, the global hematology analyzer and reagent market can be divided into blood analyzers, hemostatic analyzers, plasma protein analyzers, hemoglobin analyzers, erythrocyte sedimentation rate analyzers, coagulation analyzers, flow cytometers, slide stainers , Differential counter and hematology stains. According to the application, the blood analyzer and reagent market can be divided into anemia, blood cancer, bleeding diseases, infection-related diseases, immune system-related diseases, etc. Based on end users, the global hematology analyzer and reagent market is segmented into hospitals, commercial service providers, reference laboratories, and research and academic institutions.
The regions covered by this blood analyzer and reagent market report are North America, Europe, Asia Pacific and other regions of the world. According to the national level, the market for blood analyzers and reagents can be subdivided into the United States, Mexico, Canada, the United Kingdom, France, Germany, Italy, China, Japan, India, Southeast Asia, the Middle East (UAE, Saudi Arabia), and Egypt , Africa, etc.
Sysmex, Danaher, Nihon Kohden, Siemens, Abbott Laboratories, Boule Diagnostics, HORIBA Bio-Rad Laboratories, BioSystems, Diatron, Drew Scientific, EKF Diagnostics, Mindray, Ortho Clinical Diagnostics, Roche and others.
The increase in blood diseases and blood donations are the main factors driving the growth of the global hematology product market. However, high initial setup costs and strict regulatory environment are some of the factors restricting market growth. For example, Abbott Diagnostics introduced the CELL-DYN Ruby* blood analyzer, which costs approximately US$185,000. In addition, factors such as technological advances in blood analyzers and reagents, the combination of flow cytometry technology and blood analyzers, and mergers and acquisitions may provide growth opportunities for the market. For example, in 2012, Transasia acquired IAS Diagnostics, and Bio-Rad introduced Liquichek hematology and reticulocyte control technology.
The global hematology analyzer and reagent market is segmented into North America, Europe, Asia Pacific and Rest of the World (ROW). Due to the rising prevalence of cancer and anemia, the development of medical facilities and the increase in the number of advanced diagnostic clinics, North America is the main contributor to this market, which is some of the factors driving the market growth in this region. According to the American Cancer Society, non-Hodgkin’s lymphoma is one of the most common types of cancer in the United States, accounting for 4% of all cancers. It is estimated that 74,680 diagnoses will be made in the United States in 2018. 70% of people diagnosed with non-Hodgkin’s lymphoma live at least 5 years after being diagnosed. Such blood diseases will drive market growth. Due to untapped opportunities, especially in developing economies such as India and China, the Asia-Pacific region is expected to achieve profitable growth during the forecast period.
Get the full report: @ https://brandessenceresearch.com/healthcare/hematology-analyzer-and-reagent-market
Related report: @ https://bmrc-shubham.medium.com/chatbot-market-professional-survey-report-2021-dace5adb1283
https://bmrc-shubham.medium.com/heavy-duty-truck-market-industry-research-share-trend-2021-d45d2570db28
Post time: Feb-19-2021